article thumbnail

CPESN USA Honors 32 Community-Based Pharmacies; Awards Sponsored by Compliant Pharmacy Alliance (CPA)

Drug Topics

News FDA Updates Law and Advocacy Technology Trends Viewpoints All News Media In-Depth Insights Pharmacist View Script-Ed Expert Interviews Podcasts Conferences Conference Coverage Conference Listing Resources Disease Awareness White Board Video American Pharmacists Month Sponsored Resources CME/CE Partners Publications Drug Topics Journal Total Pharmacy (..)

article thumbnail

STAT+: Pharmalittle: We’re reading about FDA guidance on AI, meds releasing ‘forever chemicals,’ and more

STAT

As of last October, the agency had received more than 500 drug submissions with AI components going back to 2016, with a large number in the areas of oncology, neurology, and gastroenterology.   Most of the compounds came from commonly prescribed medications including antidepressants and statins.

FDA
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

STAT+: Pharmalittle: We’re reading about copycat weight loss drugs, ADHD prescriptions spiking, and more

STAT

Food and Drug Administration wants bulk production of copycat versions of popular weight-loss drugs to stop, but telehealth companies and compounding pharmacies that have fueled widespread use of the knockoffs have other plans , The Wall Street Journal writes. In 2016, Ionis won approval for an infusion called Spinraza.

article thumbnail

Mapping the crisis: How data can help fix America’s growing pharmacy deserts

pharmaphorum

Skip to main content Thursday 12 June 2025 BlueSky linkedin youtube rss User account menu Subscribe Channels Channels Digital Market Access Oncology Patients R&D Sales & Marketing Spotlight on Content type Content type Digital -News -Views & Analysis -Deep Dive -Webinars -Podcasts -Video -White Papers -Event Market Access -News -Views & (..)

article thumbnail

FDA Moving to Nonanimal Testing Methodologies in Preclinical Research

Pharmacy Times

Image Credit: filin174 | stock.adobe.com The FDA’s plan first addresses monoclonal antibodies (mAbs) but eventually could be applied to all compounds seeking FDA approval. OOCs can be used to study how a compound would interact with an organ system. The rate of successful translation of animal to human data is as little as 8%.

FDA
article thumbnail

New Frontline BTK Inhibitor Strategy Gains FDA Approval in Untreated Mantle Cell Lymphoma

Pharmacy Times

The 2016 World Health Organization classification of MCL recognizes 2 molecular subtypes that reflect divergent pathogenesis and clinical behavior 2 : Classical MCL is derived from naive B cells that lack somatic hypermutation in IGHV , do not transit through the germinal center, and express the SOX11 transcription factor.

FDA
article thumbnail

Dapagliflozin Improves Health Outcomes for Adolescents With Type 1 Diabetes

Drug Topics

October 18, 2016. Clinical trial for teens shows improved health outcomes for type 1 diabetes. News release. The Hospital For Sick Children. June 17, 2025. Accessed June 18, 2025. Type 1 diabetes. Accessed June 18, 2025. Adolescent Type 1 Diabetes Treatment With SGLT2i for hyperglycEMia & hyPerfilTration Trial (ATTEMPT).